1 August 2020 in Sao Paulo Medical Journal
BACKGROUND: Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is still the most prevalent type of osteonecrosis with clinical relevance. In Brazil, bisphosphonate use is high but there is a lack of epidemiological studies on BRONJ. OBJECTIVE: To determine the clinical profile of BRONJ in a Brazilian population through an integrative review. DESIGN AND SETTING: Integrative review of BRONJ in a Brazilian population. METHODS: Cases and clinical research on Brazilians with BRONJ between 2010 and 2019, indexed in PubMed/MEDLINE, Scopus, Web of Science and LILACS were reviewed. Age, sex, type and time of bisphosphonate intake, administration route, related diseases, region of the BRONJ, diagnostic criteria, staging, triggering factor and type of treatment were analyzed. RESULTS: Fifteen articles on 128 subjects were included. Most patients were women (82.03%); the mean age was 63 years. Intravenous zoledronic acid was mostly used (62.50%), for breast cancer treatment (46.87%). The main localization of BRONJ was the mandible (54.68%), associated mainly with tooth extractions (45.98%). The diagnostic criteria were clinical (100%) and radiographic (89.06%), mostly in stage II (68.08%). The surgical treatments were sequestrectomy (37.50%) and platelet-rich plasma (PRP) (36.71%). Microbial control was done using chlorhexidine (93.75%) and infection control using clindamycin (53.90%). CONCLUSIONS: BRONJ had higher prevalence in Brazilian women receiving treatment for breast cancer and osteoporosis. The mandible was the region most affected with a moderate stage of BRONJ, particularly when there were histories of tooth extraction and peri-implant surgery. Sequestrectomy with additional drugs and surgical therapy was the treatment most accomplished.
1 September 2019 in Anais Brasileiros de Dermatologia
The use of monoethanolamine oleate 5% is effective for the treatment of vascular malformations with low blood flow. To report a case series of vascular malformations in the mouth and oral cavity treated with monoethanolamine oleate 5%. A retrospective descriptive study was performed in electronic patient charts covering seven years. Patient demographics, diagnostic resources, lesion site, size, and number of applications of monoethanolamine oleate 5% were collected. A total of 21 vascular malformations were recorded, located mostly on the lower lip (52.3%) and resolved in a single application in 14 patients. The authors found 19 patients treated with sclerotherapy. Thirteen were women and six were men, with a mean age of 61 years. Small sample size. Sclerotherapy is an effective treatment for vascular malformations of the lips and oral cavity, with resolution after only one or two applications (n=16).
13 March 2020 in Revista Estomatológica Herediana
RTRosana Mara Adami Tucunduva
Rosana Mara Adami Tucunduva
PSPaulo Sérgio Da Silva Santos
Paulo Sérgio Da Silva Santos
ACAna Lúcia Alvares Capelozza
Ana Lúcia Alvares Capelozza
+1
Objetivo: Relatar dois casos de Sinusite Maxilar Odontogênica (SMO), diagnosticados exclusivamente por Tomografia Computadorizada de Feixe Cônico (TCFC). Relato de Caso 1: Mulher, 48 anos de idade, referiu dor difusa em face e primeiro molar superior esquerdo (PMSE) com lesão cariosa. A radiografia panorâmica mostrou uma lesão periapical bem delimitada na região do PMSE e opacificação do seio maxilar esquerdo (OSME). Apenas na TCFC houve relação entre a lesão periapical do PMSE e o seio maxilar através da ruptura cortical do assoalho do seio maxilar, espessando a mucosa do seio maxilar (EMSM). A SMO foi diagnosticada como um cisto periapical envolvendo o PMSE. Ela foi encaminhada para tratamento endodôntico. Relato de Caso 2: Homem de 33 anos referiu dor difusa na face e no primeiro molar superior direito (PMSD). A radiografia panorâmica mostrou uma rarefação óssea sem limites e perda óssea vertical ao redor das raízes da PMSD. A TCFC mostrou as mesmas características do Caso 1. Devido o grande EMSM, foi feito um diagnóstico diferencial entre a doença periodontal e o tumor do seio maxilar. O diagnóstico de SMO e doença periodontal foi feito. O seio maxilar foi a cirurgia explorada através da comunicação oral da extração dentária e da comunicação remanescente. Conclusão: A TCFC proporcionou detalhes do foco infeccioso odontogênico, comprometimento do osso alveolar e seio maxilar, assim como uma melhor visualização anatômica entre os dentes afetados e o seio maxilar, os quais não foram observados nas imagens radiográficas 2D.
8 August 2022 in Sao Paulo Medical Journal
There is a need for studies that correlate the severity of oral mucositis (OM) with chemotherapy protocols, transient myelosuppression and oral health. To analyze the severity of OM among individuals with solid tumors during hospitalization and its correlation with the type of chemotherapy, myelosuppression and oral health condition. Retrospective study at a public hospital in Bauru, state of São Paulo, Brazil, that is a regional referral center. Individuals diagnosed with solid malignant tumors who received chemotherapy during hospitalization for completion of the antineoplastic treatment cycle or who presented complications resulting from this were assessed. Twenty-eight individuals (24.3%) manifested some degree of OM. The most prevalent degrees of OM according to the World Health Organization (WHO) and modified WHO classification were grades 2 (11.3%) and 5 (4.3%), respectively. It was observed that the higher the OM-WHO (P < 0.001; r = 0.306) and modified OM-WHO (P < 0.001; r = 0.295) classifications were, the greater the oral pain reported by the individuals was. Presence of mucositis in the upper lip and buccal mucosa contributed to increased severity of OM and worsening of swallowing during hospitalization. Thus, severe OM was associated with use of the FOLFIRI protocol (folinic acid, fluorouracil and irinotecan). Individuals with tumors who presented severe OM had greater severity of oral pain and worse oral health. Use of the FOLFIRI protocol was associated with higher prevalence of severe OM, while use of 5-fluorouracil (5-FU) was correlated with worse oral condition.
1 September 2019 in Anais Brasileiros de Dermatologia (Versão em Português)
13 September 2022 in Transplantation